Lombard Odier Asset Management (Switzerland)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-267,739
Closed -$6.28M 237
2023
Q1
$6.28M Buy
267,739
+174,244
+186% +$4.98M 0.55% 51
2022
Q4
$2.54M Buy
93,495
+73,454
+367% +$3.36M 0.2% 103
2022
Q3
$1.08M Buy
+20,041
New +$1.03M 0.09% 151

Other funds holding GH

Lombard Odier Asset Management (Switzerland)'s GH Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Guardant Health (GH) in Q2 2023, closing a stake of 267,739 shares — an estimated $6.28M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in GH in Q3 2022 and held it in 3 quarters. The position peaked at $6.28M in Q1 2023. 301 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 267,739 Guardant Health shares in Q2 2023, an estimated $6.28M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Guardant Health in Q3 2022 and held it in 3 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Guardant Health position peaked at $6.28M in Q1 2023.
  • 301 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.